Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02856425
Title Trial Of Pembrolizumab And Nintedanib (PEMBIB)
Acronym PEMBIB
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.